Shrinivas Rathod

Papers

1

Total Citations

22

H-Index

1

About

Dr. Shrinivas Rathod is a leading surgical oncologist whose work centers on refining treatment paradigms for head and neck cancers, particularly oropharyngeal cancer (OPC). His most-cited paper, “Primary surgery versus (chemo)radiotherapy in oropharyngeal cancer” (2015, 22 citations), critically evaluates the evolving role of minimally invasive surgical techniques—transoral robotic surgery (TORS) and transoral laser microsurgery (TLM)—against traditional (chemo)radiotherapy. Dr. Rathod’s contribution lies in synthesizing evidence to help clinicians weigh functional preservation against oncologic outcomes, a pressing challenge in an era of rising HPV-related OPC. By highlighting the strengths and limitations of each approach, his work has informed multidisciplinary decision-making and spurred further investigation into patient-specific treatment selection. Beyond this landmark review, Dr. Rathod’s research continues to shape surgical oncology, advocating for precision in de-escalation strategies. His scholarship bridges the gap between emerging technologies and established protocols, making him a key voice in the ongoing debate over optimal OPC management. For students and researchers, his work underscores the critical importance of balancing survival with quality of life in cancer care.

Research Focus

Key Achievements

1
H-Index
1
Papers
22
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
Primary surgery versus (chemo)radiotherapy in oropharyngeal cancer
22 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 3

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago